Has Lawrence Cooper, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,119 in general payments to Lawrence Cooper, MD across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lawrence Cooper, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lawrence Cooper, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lawrence Cooper, MD

Ophthalmology · San Diego, CANPI 1518939297

Payments from drug & device makers

$4,119in general payments, 2019–2025

Across 34 payments — averaging $121.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Aerie Pharmaceuticals, Inc.$3K
Bausch & Lomb, A Division Of Bausch Health US, LLC$245
Kala Pharmaceuticals, Inc.$201
AbbVie$193
Sun Pharmaceutical Industries Inc.$192
Thea Pharma Inc.$136
plus $258 from 3 others

What the payments were for

Consulting fees$2,40058%
Food & beverage$1,71942%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Aerie Pharmaceuticals, Inc.	14	$2,895
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$245
Kala Pharmaceuticals, Inc.	5	$201
AbbVie	5	$193
Sun Pharmaceutical Industries Inc.	4	$192
Thea Pharma Inc.	1	$136
Novartis	1	$122
Alcon	1	$121
Shire North American Group Inc	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,119 in reported general payments places this provider in the 70th percentile of 2,513 ophthalmology providers in California.

See all ophthalmology providers in California →

Medicare billing

Part B allowed, 2024

$8,560

Medicare patients

Services billed

104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Latanoprost	142	$1,224
Timolol Maleate	13	$139

Paid to pharmacies, not to this prescriber.

Other ophthalmology in San Diego

William FreemanSan Diego$997K
Eric NudlemanSan Diego$752K
Robert WeinrebSan Diego$660K
Nisha AcharyaSan Francisco$33M
David WirtaNewport Beach$18.4M
Michael IpPasadena$10.2M
Raymond DouglasBeverly Hills$9.7M
Sherif El HaraziGlendale$9.2M
Daniel SchwartzSan Francisco$8M
Nikolas Londonla Jolla$6.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →